PRLR-DbsAb

N/A

Report date: 2026/03/19 17:16:48

Base Information

Drug NamePRLR-DbsAb
Drug Alias NamePRLR-DbsAb
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionProlactin receptor antagonistsAnti-CD3
TargetsProlactin receptorT cell surface glycoprotein CD3
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJecho Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJecho Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A